Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.sapharm.2021.07.019 http://scihub22266oqcxt.onion/10.1016/j.sapharm.2021.07.019 34326004!8847068!34326004     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34326004.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Res+Social+Adm+Pharm 2022 ; 18 (4): 2700-2705 Nephropedia Template TP {{tp|p=34326004|t=2022. Innovating medication reviews through a technology-enabled process |pdf=|usr=}}{{34326004}} gab.com Text Innovating medication reviews through a technology-enabled process JO: Res Social Adm Pharm http://www.kidney.de/pget.php?&tw=1&pmid=34326004 #FOAvip Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed. Twit Text FOAVip Innovating medication reviews through a technology-enabled process ????Res Social Adm Pharm http://www.kidney.de/pget.php?&tw=1&pmid=34326004 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34326004 #FOAvip English Wikipedia <ref>{{Cite pmid|34326004}}</ref> Innovating medication reviews through a technology-enabled process #MMPMID34326004 Thiruchelvam K; Byles J; Hasan SS; Kairuz T Res Social Adm Pharm 2022[Apr]; 18 (4): 2700-2705 PMID34326004show ga Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed. |*COVID-19[MESH] |*Pandemics[MESH] |Aged[MESH] |Humans[MESH] |Medication Review[MESH] |SARS-CoV-2[MESH]Innovating medication reviews through a technology-enabled process (epmc).pdf DeepDyve Pubget Overpricing